FDA Approves Regeneron Multiple Myeloma Drug With Dosing Edge Over J&J and Pfizer Meds
Regeneron Pharmaceuticals is expanding its cancer drug lineup with FDA approval of a bispecific antibody it developed for multiple myeloma, ...
Tag: Regeneron
Novartis, Regeneron, J&J, cancer research
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Readout Newsletter: Abeona, Pfizer, Regeneron, AstraZeneca
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Readout Newsletter: Immunovant, Roivant, Sanofi, Regeneron
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin Disease
Sanofi and Regeneron Pharmaceuticals drug Dupixent has won FDA approval for chronic spontaneous urticaria, introducing a new approach to the ...
Sanofi and Regeneron Biologic Drug Dupixent Notches a New FDA Approval in COPD
The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!